Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
Allie J. Widman, Lori L. McMahon
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 13
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 773
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1469-1658
Open Access | Times Cited: 445
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Eero Ċastrén, Lisa M. Monteggia
Biological Psychiatry (2021) Vol. 90, Iss. 2, pp. 128-136
Open Access | Times Cited: 348
GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
Danielle M. Gerhard, Santosh Pothula, Rong-Jian Liu, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1336-1349
Open Access | Times Cited: 266
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Ronald S. Duman
F1000Research (2018) Vol. 7, pp. 659-659
Open Access | Times Cited: 176
Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
Farhan Ali, Danielle M. Gerhard, Katherine Sweasy, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 167
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone
Journal of Psychopharmacology (2020) Vol. 35, Iss. 2, pp. 109-123
Open Access | Times Cited: 163
Mechanisms of ketamine and its metabolites as antidepressants
Evan Hess, Lace M. Riggs, Michael Michaelides, et al.
Biochemical Pharmacology (2021) Vol. 197, pp. 114892-114892
Open Access | Times Cited: 116
The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 72
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 54
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
Yunfeng Li
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107494-107494
Closed Access | Times Cited: 123
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
Antidepressant actions of ketamine engage cell-specific translation via eIF4E
Argel Aguilar‐Valles, Danilo De Gregorio, Edna Matta‐Camacho, et al.
Nature (2020) Vol. 590, Iss. 7845, pp. 315-319
Open Access | Times Cited: 99
Mechanisms of Panax ginseng action as an antidepressant
Yang Jin, Ranji Cui, Lihong Zhao, et al.
Cell Proliferation (2019) Vol. 52, Iss. 6
Open Access | Times Cited: 95
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 92
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu, Maximillian Greenwald, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 8-21
Open Access | Times Cited: 81
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia, Ling-Xiao Shao, Alex C. Kwan
Trends in Neurosciences (2020) Vol. 44, Iss. 4, pp. 260-275
Open Access | Times Cited: 81
Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine
Yihui Cui, Shaohua Hu, Hailan Hu
Trends in Neurosciences (2019) Vol. 42, Iss. 3, pp. 179-191
Closed Access | Times Cited: 79
Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents
Sriparna Ghosal, Catharine H. Duman, Rong-Jian Liu, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104669-104669
Open Access | Times Cited: 77
Cell-type specific modulation of NMDA receptors triggers antidepressant actions
Santosh Pothula, T. KATO, Rong-Jian Liu, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 9, pp. 5097-5111
Closed Access | Times Cited: 70
Ketamine for depression
Luke A. Jelen, James Stone
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 207-228
Closed Access | Times Cited: 70
The molecular pathophysiology of depression and the new therapeutics
Haihua Tian, Zhenyu Hu, Jia Xu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 65
Ketamine and the Future of Rapid-Acting Antidepressants
Lace M. Riggs, Todd D. Gould
Annual Review of Clinical Psychology (2021) Vol. 17, Iss. 1, pp. 207-231
Open Access | Times Cited: 62
Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
Vesna Lazarevic, Yunting Yang, Ivana Flais, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7425-7435
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top